Prostate cancer drug slows memory loss in women with Alzheimer's disease
from Medical Xpress
Women with Alzheimer's disease showed stable cognition for a year when a drug that is more commonly used to treat advanced prostate cancer was added to their drug regimen, according to a new study from researchers at the University of Wisconsin-Madison. This is the first time any therapy has been shown to stabilize memory loss over a year," says Dr. Craig Atwood, co-lead author of the study and associate professor of medicine at the UW School of Medicine and Public Health. The study was published in the Journal of Alzheimer's Disease.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063